Step 1: Understanding the Question:
The clinical presentation involves Postmenopausal Bleeding (PMB) in a 65-year-old woman. PMB is defined as vaginal bleeding occurring at least one year after the permanent cessation of menstruation. In clinical practice, any PMB is considered a "red flag" for malignancy until proven otherwise. Step 2: Detailed Explanation:
Endometrial Cancer: This is the most common gynecological malignancy in developed countries and primarily affects postmenopausal women (peak age 60–70 years). Over 90% of women with endometrial cancer present with vaginal bleeding or discharge.
Surgical Management: Total Hysterectomy with Bilateral Salpingo-Oophorectomy (TAH-BSO) is the standard surgical treatment and staging procedure for endometrial carcinoma. The fact that a 65-year-old underwent a hysterectomy for bleeding strongly indicates that a biopsy confirmed malignancy or high-grade hyperplasia.
Evaluation of Other Options:
- Fibroids (A): These are estrogen-dependent benign tumors. They typically undergo atrophy and calcification after menopause due to the lack of estrogen. It is highly unusual for a fibroid to cause new-onset bleeding at age 65.
- Endometriosis (B): This condition also regresses after menopause. It typically presents with pelvic pain and dysmenorrhea in premenopausal women, not isolated postmenopausal bleeding.
- Adenomyosis (C): Like fibroids, adenomyosis symptoms (menorrhagia and pain) usually resolve after menopause. It would not be the "most likely" cause of new-onset bleeding in an elderly patient.
Clinical Gold Standard: Any woman over 55 with new-onset bleeding must undergo a Transvaginal Ultrasound (TVUSG) to check endometrial thickness ($> 4$ mm is suspicious) followed by an endometrial biopsy (Pipelle or D and C).
Step 4: Final Answer:
Given the age and the symptom of postmenopausal bleeding, Endometrial cancer is the most likely and clinically significant diagnosis.
